Last reviewed · How we verify
NCT04663074
Intravascular Ultrasound (IVUS) in Complex Aortic Endovascular Interventions
trial testing IVUS control in Thoracic Aortic Aneurysm in 80 participants. Completed in 22 May 2023.
22 May 2022
Quick facts
| Lead sponsor | University Hospital Muenster |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 22 May 2020 |
| Primary completion | 22 May 2022 |
| Estimated completion | 22 May 2023 |
| Sites | 6 locations across Denmark, Germany, Italy, Sweden |
Drugs / interventions tested
- IVUS control
Conditions studied
- Thoracic Aortic Aneurysm — all drugs for Thoracic Aortic Aneurysm →
Sponsor
University Hospital Muenster
Who can join
Adults 18 to 100, any sex, with Thoracic Aortic Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to investigate the applicability of intravascular ultrasound (IVUS) in the endovascular therapy of juxta-, supra- and thoracoabdominal aortic aneurysms. The focus of the study is on the intraoperative and postoperative evaluation of the geometric data of bridging stentgrafts in terms of patency, occurrence of stenosis and/or kinking.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04663074
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Thoracic Aortic Aneurysm
Currently open trials in the same condition.
- NCT06377033 — Using the EHR to Advance Genomic Medicine Across a Diverse Health System · NA · recruiting
- NCT06353607 — Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm. · recruiting
- NCT06336213 — Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients · NA · recruiting
- NCT06094127 — Zenith Thoracic Alpha (ZTA) Post-Market Data Collection · active not recruiting
- NCT06882967 — Active Thoracic Compromised Distal LANding in TEvar · recruiting
Other University Hospital Muenster trials
Trials by the same sponsor.
- NCT07414498 — MICRO-SURG: Subgingival Microbiome in Peri-Implantitis, Regenerative, and Resective Periodontal Surgery · NA · not yet recruiting
- NCT06999174 — Multiparametric MRI for Characterization of Hepatocellular Carcinoma · recruiting
- NCT06980740 — Video-Tumorboard PLUS · recruiting
- NCT06648733 — Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care · NA · recruiting
- NCT06464302 — Investigation of the Effect of Age and Injury Severity on Short-term Intra-hospital Outcomes After Surgical Stabilized R · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04663074 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Muenster
- Last refreshed: 21 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04663074.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing